Carolina D’Alesio
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, Genomics and Rare Diseases, Cutaneous Melanoma Detection and Management, Cancer-related Molecular Pathways
Most-Cited Works
- → In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer(2016)148 cited
- → In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype(2016)78 cited
- → RNAi screens identify CHD4 as an essential gene in breast cancer growth(2016)44 cited
- → Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells(2017)42 cited
- → WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells(2019)34 cited
- → The chromodomain helicase CHD4 regulates ERBB2 signaling pathway and autophagy in ERBB2+ breast cancer cells(2019)27 cited
- → The novel diterpene 7β-acetoxy-20-hydroxy-19,20-epoxyroyleanone from Salvia corrugata shows complex cytotoxic activities against human breast epithelial cells(2019)3 cited
- → Abstract A28: Challenging new epigenetic vulnerabilities in human metastatic melanoma PDXs(2016)
- → Supplementary Methods, Figure Legends from <i>In Vivo</i> Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype(2023)
- → Data from <i>In Vivo</i> Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype(2023)